Stockscreener 앱 받기
23.39
2.86%
0.65
Amphastar Pharmaceuticals Inc 주식(AMPH)의 최신 뉴스
MSN Money - MSN
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Amphastar Pharmaceuticals Faces Downgrade Despite Strong Annual Revenue - HarianBasis.co
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7, 2026 - Black Hills Pioneer
Jefferies Downgrades Amphastar Pharmaceuticals (AMPH), Cites Lack of Meaningful Upside Catalysts - Insider Monkey
Amphastar: A Cheap Multiple Doing Exactly What It's Supposed To Do (NASDAQ:AMPH) - Seeking Alpha
After-close Q1 results: Amphastar schedules May 7 investor call - Stock Titan
Are investors undervaluing Amphastar Pharmaceuticals (AMPH) right now? - MSN
Amphastar outlines key launches and product growth drivers for 2025 - MSN
Amphastar Pharmaceuticals (AMPH) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance Australia
Are Investors Undervaluing Amphastar Pharmaceuticals (AMPH) Right Now? - Yahoo Finance
Amphastar Pharmaceuticals (AMPH) to Release Earnings on Wednesday - MarketBeat
Do options traders know something about Amphastar Pharmaceuticals stock we don't? - MSN
AMPH Price Today: Amphastar Pharmaceuticals, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Amphastar reports FDA approval for teriparatide injection - MSN
Boston Trust Walden Corp Reduces Stock Position in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals Downgrade: Stock Falls After Analyst MoveNews and Statistics - IndexBox
Jefferies downgrades Amphastar Pharmaceuticals (AMPH) - MSN
Why Amphastar Pharmaceuticals (AMPH) Shares Are Sliding Today - Yahoo Finance
Amphastar Pharmaceuticals (AMPH): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Price Down 7.4%Time to Sell? - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Earns Hold Rating from Jefferies Financial Group - MarketBeat
Why (AMPH) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Amphastar (AMPH) Stock Market Order (Bullish Sentiment) 2026-04-18Retail Trader Ideas - Xã Thanh Hà
Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To Know - Yahoo Finance
More Than 81,000 Critical Allergy Medications Recalled Nationwide - The Healthy @Reader's Digest
Needham Maintains Amphastar Pharmaceuticals(AMPH.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Amphastar Pharmaceuticals Highlights Baqsimi Milestones, Primatene Growth at Needham Conference - MarketBeat
AMPH: Baqsimi and Primatene Mist drive growth, with new launches and disciplined BD fueling expansion - TradingView
Amphastar Pharmaceuticals, Inc. ($AMPH) CEO 2025 Pay Revealed - Quiver Quantitative
[ARS] Amphastar Pharmaceuticals, Inc. SEC Filing - Stock Titan
Amphastar (NASDAQ: AMPH) outlines 2026 virtual meeting, director and pay votes - Stock Titan
Amphastar Pharmaceuticals | DEF 14A: Definitive information statements - Moomoo
How The Story Is Shifting For Amphastar Pharmaceuticals (AMPH) After Guidance Cut And New Launches - Yahoo Finance
AMPH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Barclays Lowers Price Target for Amphastar Pharma (AMPH) | AMPH Stock News - GuruFocus
Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target Lowered to $23.00 at Barclays - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Given Average Rating of "Hold" by Brokerages - MarketBeat
Understanding Momentum Shifts in (AMPH) - Stock Traders Daily
Amphastar Pharmaceuticals to Present at the 25th Annual Needham Healthcare Conference - ACCESS Newswire
0.67%
2.13%
자본화:
|
볼륨(24시간):